Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...

Fils was under pressure serving at 4-4 after a tricky couple of games. After losing a point, he approached chair umpire ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

And nearby that city, on the backfields of Peoria, a new phoenix waits to arise: Felnin Celesten, the Mariners’ 19-year-old ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...

Madison LeCroy shared new insight into husband Brett Randle's thyroid cancer battle during the Summer House After Show. Read.

Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as ...

Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that initiate the cascade of events that lead to vision.

The introduction of nanovoxelated elastic moduli in materials fabrication offers new possibilities for 3D printing, enhancing ...

The first two books of Yarros' hit romantasy series published within six months of each other. "For two and a half years it's ...

PranaX Corporation ( an emerging regenerative medicine biotechnology company, today announced that it has licensed exosome technology from The University of Texas MD Anderson Cancer Center to develop ...